Stay updated on RST-001 Trial for Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the RST-001 Trial for Retinitis Pigmentosa Clinical Trial page.

Latest updates to the RST-001 Trial for Retinitis Pigmentosa Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 supersedes v3.4.2 on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added; the government funding status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe page adds a Show glossary option and updates QC-related fields (Last Update Submitted that Met QC Criteria, Last Update Posted) and the revision label (Revision: v3.4.0), while removing older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded comprehensive updates to AGN-151597 (formerly RST-001) Phase I/II study details, including dose-escalation design, DSMC safety assessments, enrollment into Phase 2a at the maximum tolerated dose, long-term follow-up, and new US sites; removed prior RST-001 Phase I/II content and legacy enrollment/locations.SummaryDifference12%

- Check84 days agoChange DetectedLocations section now lists CA, NC, OH, and TX under a unified Locations block, with the revision tag updated to v3.3.3. Previous state-specific location blocks (California/North Carolina/Ohio/Texas Locations) were removed.SummaryDifference0.6%

Stay in the know with updates to RST-001 Trial for Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RST-001 Trial for Retinitis Pigmentosa Clinical Trial page.